Neuro-Oncologist @SmilowCancer @YaleCancer | Assistant Professor of Clinical Neurology @YaleMed | Associate Director of the Neuro-Oncology Fellowship Program
Joined July 2022
- Tweets15
- Following66
- Followers35
- Likes89
Mary Barden, MD retweeted
Honored to share my deeply personal piece in the @NEJM . Molly’s story, her love of tutus, and her enduring legacy remind me daily of the importance of compassionate, family-centered care. #grief #childloss
nejm.org/doi/full/10.1056/NE…
Mary Barden, MD retweeted
The Neuro-Oncology Academy announces SNO Grand Rounds Series Webinar: Advances in CAR-T Cell Therapies for Glioma
June 13, 2024, 11:00 AM ET.
Earn free CME!
Register today: bit.ly/3SdwW9x
Mary Barden, MD retweeted
"Every day I see people facing the diagnosis of a #braintumor. Helping people navigate this journey is endlessly humbling and my greatest privilege."
Dr. Mary Barden in a Q&A for #braintumorawarenessmonth
bit.ly/4aCmwqd
@YaleCancer @YaleMed @YNHH @NeurologyYale
Mary Barden, MD retweeted
Register for our free webinar:
➡️Smilow Shares: #BrainTumorAwareness
➡️Wednesday, May 15
➡️7:00pm
Hosted by Dr. Jennifer Moliterno, MD, FAANS, with presenters @MaryMBarden and Miri Kim, MD.
Register ⬇️ yale.zoom.us/.../register/WN…
@YaleCancer @YaleMed @YNHH @YNeurosurgery
Mary Barden, MD retweeted
New in @JTOonline from Dr @brandon_imber:
Intracranial response to #osimertinib is excellent for pts with #EGFR-mutant #NSCLC #lcsm with de novo, previously untx brain metastases. Low local failure rates support upfront osimertinib alone in selected pts.
sciencedirect.com/science/ar…
Mary Barden, MD retweeted
1/
A 68 yo M presented with days of confusion followed by increased somnolence.
An MRI was performed and demonstrated a splenial diffusion restricting lesion
What’s the differential.... and should he get steroids?
Mary Barden, MD retweeted
Here's what Dr. Lakshmi Nayak, guest editor of the December #Neurooncology issue, had to say about it. #neurology #braintumors #NeuroTwitter #MedEd
📣 Residents applying to Neuro-Oncology fellowship programs, save the date! The @NeuroOnc Adult Fellowship Educational Webinar on 12/14 will help guide the way! Click the link below for more information and to register.
soc-neuro-onc.org/WEB/About_…
Mary Barden, MD retweeted
“The future of #Neurology education is the future of neurologic care” We are so grateful for all the incredible work @yaleneuropd has done within academia to spread #Neurophilia 💚 Tune in to our latest episode to learn more! @mdgoels @BlakeBuletko @YaleNeurons #NeuroTwitter
Mary Barden, MD retweeted
Happy Friday #NeuroTwitter! Join us in celebrating our next guest speaker Dr. Jeremy Moeller @yaleneuropd of @YaleNeurons, we’re so excited to share his episode with you all next week! 🧠🙌🏽 @mdgoels @BlakeBuletko @nsaini413 #Epilepsy #Neuroscience #MedEd #TGIF 🎉
Mary Barden, MD retweeted
René Leriche said every physician carries within themselves a small cemetery where from time to time they go to pray
But you can also hold these people in your heart, in a place where you can return to celebrate them with their families (red was this patient’s favorite color 🎈)
Mary Barden, MD retweeted
Late breaking at #ASCO23: Mutations in isocitrate dehydrogenase 1 or 2 are common in low-grade glioma. The IDH inhibitor vorasidenib improved progression-free survival as compared with placebo. Full results of the INDIGO trial: nej.md/3N8N5dU
Mary Barden, MD retweeted
Register for our #SmilowShares webinar featuring
Dr. Jennifer Moliterno, Dr. Nicholas Blondin @NicholasBlondin, + Dr. Mary Barden @MaryMBarden:
➡️Smilow Shares: Brain Tumor Awareness
➡️Wed., May 10 at 7pm
➡️bit.ly/3NwRs30
@SmilowCancer @YaleMed @YNHH @YNeurosurgery
